John Walls Renal Unit, Leicester General Hospital, Leicester, UK
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, UK.
Perit Dial Int. 2019 Mar-Apr;39(2):112-118. doi: 10.3747/pdi.2018.00086. Epub 2019 Jan 18.
In-center hemodialysis (HD) has been the standard treatment for older dialysis patients, but reports suggest an associated decline in physical and cognitive function. Cross-sectional data suggest that assisted peritoneal dialysis (aPD), an alternative treatment, is associated with quality of life (QoL) outcomes that are comparable to in-center HD. We compared longitudinal changes in QoL between modalities.
We enrolled 106 aPD patients, matched with 100 HD patients from 20 renal centers in England and Northern Ireland. Patients were assessed quarterly for 2 years using the Hospital Anxiety and Depression Scale (HADS), SF-12 physical and mental scores, symptom score, Illness Intrusiveness Rating Scale (IIRS), Barthel's score, and the Renal Treatment Satisfaction Questionnaire (RTSQ). Mixed model analysis was used to assess the impact of dialysis modality on these outcomes during follow-up. values were adjusted for multiple significance testing.
Multivariate analysis showed no difference in any of the outcome measures between aPD and HD. Longitudinal trends in outcomes were also not significantly different. Higher age at baseline was associated with lower IIRS and RTSQ scores during follow-up. One-hundred and twenty-five (60.6%) patients dropped out of the study: 59 (28.6%) died, 61 (29.6%) withdrew during follow-up, and 5 (2.5%) were transplanted.
Quality of life outcomes in frail older aPD patients were equivalent to those receiving in-center HD. Assisted PD is thus a valid alternative to HD for older people with end-stage kidney disease (ESKD) wishing to dialyze at home.
中心血液透析(HD)一直是老年透析患者的标准治疗方法,但有报道称其与身体和认知功能下降有关。横断面数据表明,替代治疗方法辅助腹膜透析(aPD)与生活质量(QoL)结果相关,与中心 HD 相当。我们比较了两种治疗方式的 QoL 纵向变化。
我们招募了 106 名 aPD 患者,并在英格兰和北爱尔兰的 20 个肾脏中心与 100 名 HD 患者进行了匹配。患者在 2 年内每季度使用医院焦虑和抑郁量表(HADS)、SF-12 身体和精神评分、症状评分、疾病侵扰评分量表(IIRS)、巴氏量表和肾脏治疗满意度问卷(RTSQ)进行评估。混合模型分析用于评估随访期间透析方式对这些结果的影响。 值经过多次显著性检验调整。
多变量分析显示,aPD 和 HD 之间在任何结果测量上均无差异。在随访期间,结果的纵向趋势也没有显著差异。基线时年龄较高与随访期间较低的 IIRS 和 RTSQ 评分相关。125 名(60.6%)患者退出了研究:59 名(28.6%)死亡,61 名(29.6%)在随访期间退出,5 名(2.5%)接受了移植。
虚弱的老年 aPD 患者的生活质量结果与接受中心 HD 的患者相当。因此,对于希望在家中透析的终末期肾病(ESKD)老年患者,辅助 PD 是 HD 的有效替代方案。